Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


9th Imaging in Cancer Drug Development

13 Mar 2013 - 14 Mar 2013 - London, UK



Bookmark and Share


Join SMI at the anticipated 9th annual Imaging in Cancer Drug Development conference in March 2013 that will be the ultimate opportunity to witness presentations on the current developments surrounding oncology, pre-clinical & clinical imaging, technical innovations and advancements, imaging biomarkers in cancer drug development and the future of imaging. 

With a reputation for attracting the industry’s leading figures, this year's agenda offers an unmatched opportunity for debate and resolution of key challenges and current advances in oncology imaging. 

KEY TOPICS FOR 2013 INCLUDE:

Latest developments in fluorescence and bioluminescence for drug monitoring in xenografts

Novel target identification and lead discovery in preclinical biomarkers and radiochemistry

Strengths and limitations of whole body optical imaging with X-ray micro CT and multiphoton intravital microscopy

Overcoming challenges in nuclear tracers for multiscale imaging in oncology

Current application of PET/SPET modalities and a review of PFS (progression-free survival)

Practical tools for business expansion in the current economic climate

For more information visit http://www.smi-online.co.uk/goto/cancer-imaging5.asp

Or contact Cem Tuna on tel +44 0 207 827 6736 or email ctuna@smi-online.co.uk 



Further information
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!